Phio Pharmaceuticals Statistics
Total Valuation
PHIO has a market cap or net worth of $2.93 million. The enterprise value is -$5.56 million.
Market Cap | 2.93M |
Enterprise Value | -5.56M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PHIO has 4.59 million shares outstanding. The number of shares has increased by 83.32% in one year.
Shares Outstanding | 4.59M |
Shares Change (YoY) | +83.32% |
Shares Change (QoQ) | -14.61% |
Owned by Insiders (%) | 0.40% |
Owned by Institutions (%) | 11.04% |
Float | 4.55M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.31 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.37 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.71, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.71 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -134.70% and return on invested capital (ROIC) is -139.39%.
Return on Equity (ROE) | -134.70% |
Return on Assets (ROA) | -105.90% |
Return on Capital (ROIC) | -139.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.35M |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.01% in the last 52 weeks. The beta is 1.42, so PHIO's price volatility has been higher than the market average.
Beta (1Y) | 1.42 |
52-Week Price Change | -87.01% |
50-Day Moving Average | 0.79 |
200-Day Moving Average | 1.35 |
Relative Strength Index (RSI) | 36.37 |
Average Volume (30 Days) | 322,122 |
Short Selling Information
The latest short interest is 21,390, so 0.47% of the outstanding shares have been sold short.
Short Interest | 21,390 |
Short Previous Month | 176,627 |
Short % of Shares Out | 0.47% |
Short % of Float | 0.47% |
Short Ratio (days to cover) | 0.04 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -10.82M |
Pretax Income | -10.83M |
Net Income | -10.83M |
EBITDA | -10.64M |
EBIT | -10.83M |
Earnings Per Share (EPS) | -$5.20 |
Balance Sheet
The company has $8.49 million in cash and $35,000 in debt, giving a net cash position of $8.46 million or $1.84 per share.
Cash & Cash Equivalents | 8.49M |
Total Debt | 35,000 |
Net Cash | 8.46M |
Net Cash Per Share | $1.84 |
Equity / Book Value | 7.73M |
Book Value Per Share | 1.68 |
Working Capital | 7.69M |
Cash Flow
In the last 12 months, operating cash flow was -$10.75 million and capital expenditures -$5,000, giving a free cash flow of -$10.75 million.
Operating Cash Flow | -10.75M |
Capital Expenditures | -5,000 |
Free Cash Flow | -10.75M |
FCF Per Share | -$5.16 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PHIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -83.32% |
Shareholder Yield | -83.32% |
Earnings Yield | -374.18% |
FCF Yield | -371.70% |
Analyst Forecast
The average price target for PHIO is $4.00, which is 527.16% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 527.16% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 26, 2023. It was a reverse split with a ratio of 1:12.
Last Split Date | Jan 26, 2023 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |